The Replacement of ATP by the Competitive Inhibitor Emodin Induces Conformational Modifications in the Catalytic Site of Protein Kinase CK2*

The structure of a complex between the catalytic subunit of Zea mays CK2 and the nucleotide binding site-directed inhibitor emodin (3-methyl-1,6,8-trihydroxyanthraquinone) was solved at 2.6-Å resolution. Emodin enters the nucleotide binding site of the enzyme, filling a hydrophobic pocket between the N-terminal and the C-terminal lobes, in the proximity of the site occupied by the base rings of the natural co-substrates. The interactions between the inhibitor and CK2α are mainly hydrophobic. Although the C-terminal domain of the enzyme is essentially identical to the ATP-bound form, the β-sheet in the N-terminal domain is altered by the presence of emodin. The structural data presented here highlight the flexibility of the kinase domain structure and provide information for the design of selective ATP competitive inhibitors of protein kinase CK2.

[1]  K. Livak.  Detailed structure of the Drosophila melanogaster stellate genes and their transcripts. , 1990, Genetics.

[2]  S. Hanks,et al.  Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. , 1991, Methods in enzymology.

[3]  S. K. Lee,et al.  Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor. , 1999, Planta medica.

[4]  R. Weinmann,et al.  Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription. , 1986, The Journal of biological chemistry.

[5]  H. Mett,et al.  Protein tyrosine kinase and protein kinase C inhibition by fungal anthraquinones related to emodin. , 1995, The Journal of antibiotics.

[6]  R. Cardiff,et al.  p53 deficiency and misexpression of protein kinase CK2α collaborate in the development of thymic lymphomas in mice , 1998, Oncogene.

[7]  L. Pinna,et al.  Purification and characterization of maize seedling casein kinase IIB, a monomeric enzyme immunologically related to the alpha subunit of animal casein kinase-2. , 1992, European journal of biochemistry.

[8]  D. Schomburg,et al.  Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 Å resolution , 1998, The EMBO journal.

[9]  L. Pinna.  Casein kinase 2: an 'eminence grise' in cellular regulation? , 1990, Biochimica et biophysica acta.

[10]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[11]  L. Pinna,et al.  Ribofuranosyl-benzimidazole derivatives as inhibitors of casein kinase-2 and casein kinase-1. , 1990, European journal of biochemistry.

[12]  D. Shugar,et al.  Halogenated benzimidazoles and benzotriazoles as selective inhibitors of protein kinases CK I and CK II from Saccharomyces cerevisiae and other sources. , 1995, Biochemical and biophysical research communications.

[13]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[14]  R. Geahlen,et al.  Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. , 1992, Journal of natural products.

[15]  G. Hortobagyi,et al.  Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties , 1998, Oncogene.

[16]  D. Fabbro,et al.  Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2. , 1995, European journal of biochemistry.

[17]  O. Issinger,et al.  Protein kinase CK2 and its role in cellular proliferation, development and pathology , 1999, Electrophoresis.

[18]  C. Allende,et al.  Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  Dietmar Schomburg,et al.  GTP plus water mimic ATP in the active site of protein kinase CK2 , 1999, Nature Structural Biology.

[20]  S. Kawamoto,et al.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. , 1984, Biochemistry.

[21]  L. Pinna,et al.  Protein Kinase CK2α′ Is Induced by Serum as a Delayed Early Gene and Cooperates with Ha-ras in Fibroblast Transformation* , 1998, The Journal of Biological Chemistry.

[22]  L. Pinna,et al.  Protein kinase CK2 ("casein kinase-2") and its implication in cell division and proliferation. , 1997, Progress in cell cycle research.

[23]  P. Leder,et al.  Tal‐1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. , 1996, The EMBO journal.

[24]  D. Schomburg,et al.  Expression, purification and crystallization of the catalytic subunit of protein kinase CK2 from Zea mays. , 1998, Acta crystallographica. Section D, Biological crystallography.

[25]  P. Leder,et al.  Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle , 1995, Science.

[26]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[27]  T. Hunter,et al.  The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.